Trulieve Cannabis (OTCMKTS:TCNNF) PT Raised to $19.00 – Defense World

Trulieve Cannabis (OTCMKTS:TCNNFGet Free Report) had its price objective raised by equities research analysts at Roth Mkm from $16.00 to $19.00 in a research note issued to investors on Friday, Benzinga reports. The brokerage presently has a “buy” rating on the stock. Roth Mkm’s price objective suggests a potential upside of 63.79% from the stock’s previous close.

Separately, Needham & Company LLC increased their target price on shares of Trulieve Cannabis from $13.50 to $14.50 and gave the company a “buy” rating in a research report on Friday.

Get Our Latest Stock Analysis on Trulieve Cannabis

Trulieve Cannabis Price Performance TCNNF stock opened at $11.60 on Friday. Trulieve Cannabis has a one year low of $3.42 and a one year high of $14.50. The firm has a 50-day simple moving average of $11.25 and a two-hundred day simple moving average of $8.27. Trulieve Cannabis Company Profile

(Get Free Report)

Trulieve Cannabis Corp., together with its subsidiaries, operates as a cannabis retailer. The company cultivates, processes, and manufactures cannabis products and distributes its products to its dispensaries, as well as through home delivery. It sells flowers, edibles, vapes, creams, balms, salves, lotions, vaporizers, batteries, cartridge, concentrates, topicals, capsules,

Read More

Scroll to Top
Florida Dispensaries